Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Dudley

Showing results (181-190 of 226) with videos related to

Pageof 23
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2003
High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigensRichard A Morgan, Mark E Dudley, Yik Y L Yu, et al.
Human Gene Therapy|May 6, 2005
Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functionsMarybeth S Hughes, Yik Y L Yu, Mark E Dudley, et al.
Oncology Research|January 1, 1993
Evaluation of new anticancer agents against the MIA PaCa-2 and PANC-1 human pancreatic carcinoma xenograftsR M Schultz, R L Merriman, J E Toth, et al.
Human Gene Therapy|May 1, 2008
Adoptive cell therapy for patients with melanoma, using tumor-infiltrating lymphocytes genetically engineered to secrete interleukin-2Bianca Heemskerk, Ke Liu, Mark E Dudley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2013
Mutated PPP1R3B is recognized by T cells used to treat a melanoma patient who experienced a durable complete tumor regressionYong-Chen Lu, Xin Yao, Yong F Li, et al.
Journal for Immunotherapy of Cancer|November 22, 2017
Single-cell multiplexed cytokine profiling of CD19 CAR-T cells reveals a diverse landscape of polyfunctional antigen-specific responseQiong Xue, Emily Bettini, Patrick Paczkowski, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1996
Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center studyC Wang, D R Eyre, R Clark, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2014
Efficient identification of mutated cancer antigens recognized by T cells associated with durable tumor regressionsYong-Chen Lu, Xin Yao, Jessica S Crystal, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 22, 2001
Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanomaM E Dudley, J Wunderlich, M I Nishimura, et al.
Journal of Andrology|April 9, 2011
Reexamination of pharmacokinetics of oral testosterone undecanoate in hypogonadal men with a new self-emulsifying formulationAnthony Y Yin, Michelle Htun, Ronald S Swerdloff, et al.
Pageof 23

Showing results (181-190 of 226) with videos related to

Sort By:
Pageof 23
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2003
High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigensRichard A Morgan, Mark E Dudley, Yik Y L Yu, et al.
Human Gene Therapy|May 6, 2005
Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functionsMarybeth S Hughes, Yik Y L Yu, Mark E Dudley, et al.
Oncology Research|January 1, 1993
Evaluation of new anticancer agents against the MIA PaCa-2 and PANC-1 human pancreatic carcinoma xenograftsR M Schultz, R L Merriman, J E Toth, et al.
Human Gene Therapy|May 1, 2008
Adoptive cell therapy for patients with melanoma, using tumor-infiltrating lymphocytes genetically engineered to secrete interleukin-2Bianca Heemskerk, Ke Liu, Mark E Dudley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2013
Mutated PPP1R3B is recognized by T cells used to treat a melanoma patient who experienced a durable complete tumor regressionYong-Chen Lu, Xin Yao, Yong F Li, et al.
Journal for Immunotherapy of Cancer|November 22, 2017
Single-cell multiplexed cytokine profiling of CD19 CAR-T cells reveals a diverse landscape of polyfunctional antigen-specific responseQiong Xue, Emily Bettini, Patrick Paczkowski, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1996
Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men--a clinical research center studyC Wang, D R Eyre, R Clark, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2014
Efficient identification of mutated cancer antigens recognized by T cells associated with durable tumor regressionsYong-Chen Lu, Xin Yao, Jessica S Crystal, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 22, 2001
Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanomaM E Dudley, J Wunderlich, M I Nishimura, et al.
Journal of Andrology|April 9, 2011
Reexamination of pharmacokinetics of oral testosterone undecanoate in hypogonadal men with a new self-emulsifying formulationAnthony Y Yin, Michelle Htun, Ronald S Swerdloff, et al.
Pageof 23